Skip to main content
Quest Diagnostics

ANCA-Negative Pauci-Immune Necrotizing Glomerulonephritis in the Setting of Multisystem Inflammatory Syndrome in Children

ANCA-Negative Pauci-Immune Necrotizing Glomerulonephritis in the Setting of Multisystem Inflammatory Syndrome in Children

Authors: VanBeek CA, Alammar N, Abid Q

Citation: Kidney Med. 2026 Jan 10. doi: 10.1016/j.xkme.2026.101254. Online ahead of print.

Specialties: Infectious disease, COVID-19, Pediatrics, Nephrology, Cardiology, Immunology

Related content

On-Demand Webinar
The Continuum of Kidney Disease Care: From Identification to referral
Publication
A multi-center retrospective cohort study defines the spectrum of kidney pathology in Coronavirus 2019 Disease (COVID-19)
Audio Podcast
Actions From Insight: Your Kidney Friendly Nutrition Plan
Publication
Coronavirus Disease 2019 (COVID-19) Real World Data Infrastructure: A Big-Data Resource for Study of the Impact of COVID-19 in Patient Populations With Immunocompromising Conditions
Audio Podcast
Instant Insight: Kidney Profile and Cystatin C
Conference Presentation
Seroprevalence of SARS-CoV-2 IgG Spike and Nucleocapsid Antibodies in Northeast Population: 2023-2024

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.